Protocol 2: chronic muscular back pain (intermediate) Goal: Address long-standing muscular tension, trigger points, and chronic strain patterns Peptides: BPC-157 : 500mcg twice daily for enhanced effect TB-500 : 2.5mg twice weekly during loading, then 2mg weekly Duration: 8-12 weeks for chronic conditions Why this works: Higher BPC-157 dosing addresses stubborn chronic issues
An omnivorous diet allows for the B12 intake through animal products (with a bioavailability ranging from 24% to 36% in eggs, up to 65% in lean meat) (Doets et al., 2013), while vitamin B12 is scarce or absent in diets including little or no animal products
B12 injections are suitable for most individuals, especially those with a confirmed B12 deficiency, vegans or vegetarians (as B12 is primarily found in animal products), or anyone looking to boost their energy and wellbeing
References: Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L. B., Pavlov, K. H., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Staresinic, M., Strbe, S., Knezevic, M., Sola, M., Kokot, A., Sever, M., Sikiric, P. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.Frontiers in pharmacology,12, 627533. Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., & Bock-Marquette, I. (2021). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies.Cells,10(6), 1343. National Center for Biotechnology Information. PubChem Compound Summary for CID 132558700, CID 132558700 PubChem, National Center for Biotechnology Information. PubChem Compound Summary for CID 9941957 PubChem, Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008 May 15;453(7193):314-21. doi: 10.1038/nature07039. PMID: 18480812. Santra, M., Zhang, Z. G., Yang, J., Santra, S., Santra, S., Chopp, M., & Morris, D. C. (2014). Thymosin 4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway.The Journal of biological chemistry,289(28), 1950819518. Sikiric, Predrag et al. Brain-gut Axis and Pentadecapeptide BPC-157: Theoretical and Practical Implications. Current neuropharmacology vol. 14,8 (2016): 857-865. Chang, Chung-Hsun et al. The promoting effect of pentadecapeptide BPC-157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology (Bethesda, Md. : 1985) vol. 110,3 (2011): 774-80. doi:10.1152/japplphysiol.00945.2010. Katherine M. Malinda et.al, Thymosin 4 Accelerates Wound Healing, Journal of Investigative Dermatology, Volume 113, Issue 3, 1999, Pages 364-368, ISSN 0022-202X, Study of Thymosin Beta 4 in Patients With Pressure Ulcers. S Seiwerth, et al. BPC-157s effect on healing. Journal of physiology, Paris vol. 91,3-5 (1997): 173-8. doi:10.1016/s0928-4257(97)89480-6. Xu B, Yang M, Li Z, Zhang Y, Jiang Z, Guan S, Jiang D. Thymosin 4 enhances the healing of medial collateral ligament injury in rat. Regul Pept. 2013 Jun 10;184:1-5. doi: 10.1016/j.regpep.2013.03.026. Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T, Sever M, Kocijan A, Berkopic L, Radic B, Buljat G, Anic T, Zoricic I, Bojanic I, Seiwerth S, Sikiric P. Impact of pentadecapeptide BPC-157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010 Mar;16(3):BR81-88. PMID: 20190676. Srivastava, D., Ieda, M., Fu, J., & Qian, L. (2012). Cardiac repair with thymosin 4 and cardiac reprogramming factors.Annals of the New York Academy of Sciences,1270, 6672. Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M., & Srivastava, D. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.Nature,432(7016), 466472
& Forsdyke, D
